Dijana Hadžiomerović, M. D. , Bernhard Rabenbauer, M. D

Slides:



Advertisements
Similar presentations
Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States  David B. Seifer, M.D., Valerie.
Advertisements

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Endocrine and cardiometabolic cord blood characteristics of offspring born to mothers with and without polycystic ovary syndrome  Nadine M.P. Daan, M.D.,
Male contraception Fertility and Sterility
Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome  Elisabeth Lerchbaum,
Divergent effects of a combined hormonal oral contraceptive on insulin sensitivity in lean versus obese women  Kai I. Cheang, Pharm.D., M.S., Paulina.
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Comparison of hormonal and metabolic markers after a high-fat, Western meal versus a low-fat, high-fiber meal in women with polycystic ovary syndrome 
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D
Michael M. Alper, M.D.  Fertility and Sterility 
Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study 
Ramifications of adolescent menstrual cycles ≥42 days in young adults
Dennis J. Hand, Ph. D. , Vanessa L. Short, Ph. D. , M. P. H. , Diane J
Hepatitis and reproduction
The spectrum of androgen excess disorders
Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome  Shirei Ohgi, M.D., Koji Nakagawa, M.D., Ph.D., Rieko Kojima,
Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids  Isabelle.
Impact of fatness, insulin, and gynecological age on luteinizing hormone secretory dynamics in adolescent females  Josephine Z. Kasa-Vubu, M.D., Vandana.
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels 
Shahin Ghadir, M.D., Ricardo Azziz, M.D., M.P.H., M.B.A. 
Medical treatment of ectopic pregnancy: a committee opinion
Rebecca A. Feldman, M. D. , Kathleen O'Neill, M. D. , Samantha F
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
Levonorgestrel effects on serum androgens, sex hormone–binding globulin levels, hair shaft diameter, and sexual function  George Kovalevsky, M.D., Susan.
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Potential diagnostic utility of intermittent administration of short-acting gonadotropin- releasing hormone agonist in gonadotropin deficiency  Carrie.
Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with.
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Oocyte cryopreservation
Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular.
Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens 
With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice?  Jacques Donnez, M.D., Ph.D., Olivier.
Robert F. Casper, M.D.  Fertility and Sterility 
Cardiovascular risk in normal weight, eumenorrheic, nonhirsute daughters of patients with polycystic ovary syndrome: a pilot study  Cesare Battaglia,
The biphasic pattern of end-expiratory carbon dioxide pressure: a method for identification of the fertile phase of the menstrual cycle  Dijana Hadžiomerović,
Polycystic ovarian disease unmasked by pulsatile GnRH therapy in a subgroup of women with hypothalamic amenorrhea  Verena Mattle, M.D., Aysen Bilgyicildirim,
Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity  Jean-Patrice Baillargeon, M.D.,
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled.
Increased secretion of amylin in women with polycystic ovary syndrome
Fertility and Sterility
Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation  Allison Styne-Gross, M.D., Karen.
P-425 Fertility and Sterility Volume 86, Issue 3, (September 2006)
Banu Ucar, M. D. , Volkan Noyan, M. D. , Osman Caglayan, M. D
Naloxone decreases insulin secretion in hyperinsulinemic postmenopausal women and may positively affect hormone replacement therapy  Francesco Cucinelli,
Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women  Hong Zang, M.D., Kjell Carlström,
Antecubital vein venous sampling does not distort circulating levels of peptide and sex steroid hormones  Michael P. Diamond, M.D., Michael Kruger, M.S.,
Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion.
L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing 
Effect of gonadotropin-releasing-hormone-induced hypogonadism on insulin action as assessed by euglycemic clamp studies in men  Subodhsingh Chauhan, M.D.,
Fertility and Sterility: an evaluation
Obesity and androgens: facts and perspectives
Paolo Moghetti, M.D.  Fertility and Sterility 
Counteraction during movement of spermatozoa by Trichomonas vaginalis observed by visual image analysis: a possible cause of female infertility  Viroj.
George Christodoulakos, M. D. , Irene Lambrinoudaki, M. D
Current evaluation of amenorrhea
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Serum anti-Mullerian hormone dynamics during stimulated cycles by aromatase inhibitor anastrozole and clomiphene citrate in women with infertility  H.-H.
Comparison of the Ovulation Induction and Hormone Profile Between Anastrozole and Clomiphene Citrate in Women With Infertility  H. Wu, P. Chen, N.M. Wang,
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy  Helena J. Teede, Ph.D., Caroline Meyer, Ph.D.,
In vitro sildenafil citrate use as a sperm motility stimulant
Saad Elzanaty, M.D., Ph.D., Johan Malm, M.D., Ph.D. 
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome  Robert P. Kauffman,
Ongoing pregnancy rates in intrauterine insemination are affected by late follicular- phase progesterone levels  Antonio Requena, M.D., María Cruz, Ph.D.,
Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient’s body mass index and the number of larger follicles 
Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome  Kevin H. Maas, M.D., Ph.D., Sandy Chuan,
Serum anti-müllerian hormone levels in women with secondary amenorrhea
Tamer M. Said, M. D. , Geetha Ranga, M. D. , Ashok Agarwal, Ph. D. , H
Presentation transcript:

Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women  Dijana Hadžiomerović, M.D., Bernhard Rabenbauer, M.D., Ludwig Wildt, M.D.  Fertility and Sterility  Volume 86, Issue 3, Pages 651-657 (September 2006) DOI: 10.1016/j.fertnstert.2006.01.039 Copyright © 2006 American Society for Reproductive Medicine Terms and Conditions

FIGURE 1 Serum concentration (mean ± SD) of LH/FSH, T, free T (fT), sex hormone-binding globulin (SHBG), and DHEAS (left ordinate) and free androgen index (FAI) (right ordinate) in 39 women with hyperandrogenemia and hyperinsulinemia at baseline and after the administration of naltrexone (50 mg/d) for ≥3 weeks. The women were studied before and during naltrexone treatment. *P<.05; **P<.01; ***P<.001 (t-test for paired samples) for comparison with baseline values in the same group. Hadzžiomerović. Opioid blockade and hyperandrogenemia. Fertil Steril 2006. Fertility and Sterility 2006 86, 651-657DOI: (10.1016/j.fertnstert.2006.01.039) Copyright © 2006 American Society for Reproductive Medicine Terms and Conditions

FIGURE 2 Body mass index in 39 hyperandrogenemic, hyperinsulinemic patients with three different levels of severity of hyperinsulinemia (A = slight; B = moderate; C = severe hyperinsulinemia) before and during naltrexone treatment. Data are expressed as the mean ± SD. None of the three groups shows a significant change in body mass index. Hadzžiomerović. Opioid blockade and hyperandrogenemia. Fertil Steril 2006. Fertility and Sterility 2006 86, 651-657DOI: (10.1016/j.fertnstert.2006.01.039) Copyright © 2006 American Society for Reproductive Medicine Terms and Conditions

FIGURE 3 Area under the curve (AUC) of insulin concentration before and after 3–9 weeks of naltrexone treatment for each patient. The levels of insulin were significantly lower (P<.01, t-test for paired samples) when compared to baseline values in all 39 hyperinsulinemic, hyperandrogenemic women. Hadzžiomerović. Opioid blockade and hyperandrogenemia. Fertil Steril 2006. Fertility and Sterility 2006 86, 651-657DOI: (10.1016/j.fertnstert.2006.01.039) Copyright © 2006 American Society for Reproductive Medicine Terms and Conditions

FIGURE 4 Area under the curve (AUC) of glucose, insulin, and C-peptide concentrations after 75-g glucose load in hyperandrogenemic women before (•) and during (○) the naltrexone treatment. Data are expressed as mean ± SD. When OGTT was repeated during naltrexone administration, the increase in glucose concentrations was not different from that observed before treatment. The levels of insulin were strikingly lower (P<.01, t-test for paired samples) when compared to baseline values. The increase in C-peptide concentrations was influenced to a much lesser extent than that of insulin. Hadzžiomerović. Opioid blockade and hyperandrogenemia. Fertil Steril 2006. Fertility and Sterility 2006 86, 651-657DOI: (10.1016/j.fertnstert.2006.01.039) Copyright © 2006 American Society for Reproductive Medicine Terms and Conditions